Bristol-Myers Squibb Co. (NYSE:BMY)

Pfizer logo

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

With the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large biotechnology stocks were not the lone rangers when it came to ...
Read Full Story »
Pills

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Wall Street firms are famous for their ability to throw conference after conference, year after year. Some are highly respected, and a must-attend for investment firms and portfolio managers. Others ...
Read Full Story »
DNA

Mallinckrodt May Have to Pay More for Cadence

Cadence Pharmaceuticals Inc. (NASDAQ: CADX) agreed Tuesday to be bought out by Mallinckrodt PLC (NYSE: MNK) for $1.3 billion, or $14 a share, in cash. There appears to be some speculation ...
Read Full Story »
NYSE-flag

The Best of the Best Picks of the Credit Suisse Top 50 Stocks

Most of the firms that we cover on Wall Street have presented their high conviction stock picks for 2014. The analysts at Credit Suisse have taken a little bit longer ...
Read Full Story »
Pills

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

The wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company ViroPharma (NASDAQ: ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: ARM, Crocs, GE, NOV and More

Earnings season is in full swing and equities are challenging new highs almost daily. Traders and investors are looking for stocks to buy and for ideas on which stocks to ...
Read Full Story »
Pills

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

The drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week's government shutdown and impending debt ceiling weighed heavily on biotech stocks. Credit ...
Read Full Story »
Pills

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

As the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their coverage universe to find ...
Read Full Story »
Bull and Bear figures

Closing Bell for Wednesday on Wall Street: Markets Blunted on Fed Comments, Minutes

U.S. equity markets opened barely higher this morning following a report that mortgage loan applications had fallen by 9.8% from the previous week, on top of a 7% decline for ...
Read Full Story »
Wall St Bull statue

Top Analyst Upgrades and Stocks to Buy: Chesapeake, Citigroup, Monster and More

Investors and traders are always looking for new research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to find ...
Read Full Story »
Bull and Bear figures

Closing Bell for Wednesday on Wall Street: Markets Open Soft, Close with a Flourish

U.S. equity markets opened slightly lower this morning following a number of data releases related to the U.S. economy. Producer prices declined in April and the New York manufacturing index ...
Read Full Story »
Pills

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

One of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for ...
Read Full Story »
Pfizer logo

Viagra for Sale Online: Will Other Drug Companies Follow Pfizer?

Yesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to patients is a genuinely ground-breaking deal. The big drug companies like ...
Read Full Story »
pills

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

With the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or ...
Read Full Story »
76764023

Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MNKD, BAC)

According to the Center for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes ...
Read Full Story »